<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Liver Problems Linked To Arthritis Drug</title><link>http://articles.mercola.com/sites/articles/archive/2001/03/24/arthritis-drug-part-two.aspx</link><description>Severe liver reactions -- some with fatal outcomes -- have occurred in patients treated with Aventis' novel rheumatoid arthritis drug Arava (leflunomide), according to the European Medicines Evaluation Agency (EMEA). In a public statement on its Web site</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>